Want to receive updates for this keyword?
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign UpOncocardiology
• keyword#1
Csaba András Nagy, Mária Lódi, Ingrid Balogh, Dániel Czuriga, Judit Kocsis
It is well-known that modern oncotherapy significantly reduced the mortality of malignant diseases. However, serious side effects of the applied cancer therapies have evolved, which may adversely affect the cardiovascular system. Early side effects often limit therapeutic success of oncotherapy and may require treatment interruption, while late-onset side effects can adversely influence the long-term survival of patients recovering from cancer. Oncocardiology is a new medical field gaining more and more attention...
September 20, 2017: Magyar Onkologia
#2
Hui-Ming Chang, Edward T H Yeh
No abstract text is available yet for this article.
July 1, 2017: JAMA Cardiology
#3
Siew Lian Leong, Nathorn Chaiyakunapruk, Shaun Wen Huey Lee
No abstract text is available yet for this article.
July 1, 2017: JAMA Cardiology
#4
Jennifer Cautela, Nathalie Lalevee, Franck Thuny
No abstract text is available yet for this article.
July 1, 2017: JAMA Cardiology
#5
EDITORIAL
Parva K Bhatt, Tochi Okwuosa
No abstract text is available yet for this article.
February 2017: Postgraduate Medical Journal
#6
Edward T H Yeh, Hui-Ming Chang
Importance: Oncocardiology is a medical discipline that focuses on the identification, prevention, and treatment of cardiovascular complications related to cancer therapy. This discipline has gained interest from the cardiology community in recent years because of a remarkable increase in the number of cancer survivors and the proliferation of new cancer therapies causing cardiovascular complications, such as hypertension, heart failure, vascular complications, and cardiac arrhythmia...
December 1, 2016: JAMA Cardiology
#7
REVIEW
I Latorzeff, G Ploussard, J Guillotreau, F Jonca, P Labarthe, G Rollin, J-B Beauval, A Pathak
Prostate cancer, the most frequent cancer in man, is an adenocarcinoma sensible to chemical castration in more than 80% of cases due to its hormonal dependency. Androgen deprivation is the treatment for advanced cancer and can be associated with radiotherapy locally or in locally advanced situations. Multidisciplinary therapeutic choice depends on patient age and co-morbidities and clinical stage. The impact of hormonal treatment confers varied side effects and cardiovascular effects are now better known. Responsible mechanisms of this cardiotoxicity are at the same time direct but also indirect by metabolic thermogenic effects...
July 2016: Cancer Radiothérapie: Journal de la Société Française de Radiothérapie Oncologique
#8
REVIEW
Rohit Moudgil, Edward T H Yeh
Tremendous strides have been made in the treatment of various oncological diseases such that patients are surviving longer and are having better quality of life. However, the success has been tainted by the iatrogenic cardiac toxicities. This is especially concerning in the younger population who are facing cardiac disease such as heart failure in their 30s and 40s as the consequence of the anthracycline's side effects (used for childhood leukemia and lymphoma). This resulted in the awareness of cardiotoxic effects of anticancer drugs and emergence of a new discipline: oncocardiology...
July 2016: Canadian Journal of Cardiology
#9
EDITORIAL
C Lestuzzi
No abstract text is available yet for this article.
July 31, 2013: International Journal of Cardiology
1
Fetching more papers... 
